Dr Ing Hc Stock Net Income
| DRPRF Stock | USD 49.69 0.69 1.41% |
As of the 27th of January, Dr Ing owns the Information Ratio of (0.05), standard deviation of 2.22, and Market Risk Adjusted Performance of (0.11). Dr Ing hc technical analysis allows you to utilize past data patterns in order to determine a pattern that computes the direction of the firm's future prices. Please confirm Dr Ing hc standard deviation, as well as the relationship between the maximum drawdown and kurtosis to decide if Dr Ing hc is priced favorably, providing market reflects its prevailing price of 49.69 per share. Given that Dr Ing hc has information ratio of (0.05), we urge you to verify Dr Ing's latest market performance to make sure the company can sustain itself in the future.
Dr Ing's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Dr Ing's valuation are provided below:Dr Ing hc does not right now have any fundamental measures for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. DRPRF |
Dr Ing 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Dr Ing's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Dr Ing.
| 10/29/2025 |
| 01/27/2026 |
If you would invest 0.00 in Dr Ing on October 29, 2025 and sell it all today you would earn a total of 0.00 from holding Dr Ing hc or generate 0.0% return on investment in Dr Ing over 90 days. Dr Ing is related to or competes with Dr Ing, Mahindra Mahindra, Volkswagen, Volkswagen, Volkswagen, Volkswagen, and Bayerische Motoren. Porsche AG engages in automotive and financial services businesses More
Dr Ing Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Dr Ing's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Dr Ing hc upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.05) | |||
| Maximum Drawdown | 15.07 | |||
| Value At Risk | (4.48) | |||
| Potential Upside | 3.32 |
Dr Ing Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Dr Ing's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Dr Ing's standard deviation. In reality, there are many statistical measures that can use Dr Ing historical prices to predict the future Dr Ing's volatility.| Risk Adjusted Performance | (0) | |||
| Jensen Alpha | (0.05) | |||
| Total Risk Alpha | (0.25) | |||
| Treynor Ratio | (0.12) |
Dr Ing January 27, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0) | |||
| Market Risk Adjusted Performance | (0.11) | |||
| Mean Deviation | 1.06 | |||
| Coefficient Of Variation | (9,233) | |||
| Standard Deviation | 2.22 | |||
| Variance | 4.93 | |||
| Information Ratio | (0.05) | |||
| Jensen Alpha | (0.05) | |||
| Total Risk Alpha | (0.25) | |||
| Treynor Ratio | (0.12) | |||
| Maximum Drawdown | 15.07 | |||
| Value At Risk | (4.48) | |||
| Potential Upside | 3.32 | |||
| Skewness | 0.2869 | |||
| Kurtosis | 4.72 |
Dr Ing hc Backtested Returns
Dr Ing hc retains Efficiency (Sharpe Ratio) of -0.0895, which denotes the company had a -0.0895 % return per unit of price deviation over the last 3 months. Dr Ing exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Dr Ing's Standard Deviation of 2.22, market risk adjusted performance of (0.11), and Information Ratio of (0.05) to check the risk estimate we provide. The firm owns a Beta (Systematic Risk) of 0.27, which means not very significant fluctuations relative to the market. As returns on the market increase, Dr Ing's returns are expected to increase less than the market. However, during the bear market, the loss of holding Dr Ing is expected to be smaller as well. At this point, Dr Ing hc has a negative expected return of -0.19%. Please make sure to confirm Dr Ing's treynor ratio, and the relationship between the standard deviation and kurtosis , to decide if Dr Ing hc performance from the past will be repeated in the future.
Auto-correlation | -0.18 |
Insignificant reverse predictability
Dr Ing hc has insignificant reverse predictability. Overlapping area represents the amount of predictability between Dr Ing time series from 29th of October 2025 to 13th of December 2025 and 13th of December 2025 to 27th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Dr Ing hc price movement. The serial correlation of -0.18 indicates that over 18.0% of current Dr Ing price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.18 | |
| Spearman Rank Test | 0.28 | |
| Residual Average | 0.0 | |
| Price Variance | 3.56 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Dr Ing hc reported net income of 4.03 B. This is much higher than that of the Consumer Cyclical sector and 14.16% lower than that of the Auto Manufacturers industry. The net income for all United States stocks is significantly lower than that of the firm.
DRPRF Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Dr Ing's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Dr Ing could also be used in its relative valuation, which is a method of valuing Dr Ing by comparing valuation metrics of similar companies.Dr Ing is currently under evaluation in net income category among its peers.
DRPRF Fundamentals
| Profit Margin | 0.14 % | |||
| Operating Margin | 0.20 % | |||
| Shares Owned By Insiders | 7.00 % | |||
| Shares Owned By Institutions | 13.52 % | |||
| Revenue | 36.76 B | |||
| Gross Profit | 8.99 B | |||
| EBITDA | 9.38 B | |||
| Net Income | 4.03 B | |||
| Cash And Equivalents | 5.87 B | |||
| Cash Per Share | 64.53 X | |||
| Total Debt | 9.75 B | |||
| Debt To Equity | 0.65 % | |||
| Current Ratio | 1.12 X | |||
| Book Value Per Share | 251.94 X | |||
| Cash Flow From Operations | 6.42 B | |||
| Number Of Employees | 36.52 K |
About Dr Ing Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Dr Ing hc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Dr Ing using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Dr Ing hc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in DRPRF Pink Sheet
Dr Ing financial ratios help investors to determine whether DRPRF Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in DRPRF with respect to the benefits of owning Dr Ing security.